<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1376" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1376/" /><meta name="ncbi_pagename" content="Schimke Immunoosseous Dysplasia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Schimke Immunoosseous Dysplasia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Schimke Immunoosseous Dysplasia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/02/11" /><meta name="citation_author" content="Marie Morimoto" /><meta name="citation_author" content="David B Lewis" /><meta name="citation_author" content="Thomas Lücke" /><meta name="citation_author" content="Cornelius F Boerkoel" /><meta name="citation_pmid" content="20301550" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1376/" /><meta name="citation_keywords" content="SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1" /><meta name="citation_keywords" content="SMARCAL1" /><meta name="citation_keywords" content="Schimke Immunoosseous Dysplasia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Schimke Immunoosseous Dysplasia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Marie Morimoto" /><meta name="DC.Contributor" content="David B Lewis" /><meta name="DC.Contributor" content="Thomas Lücke" /><meta name="DC.Contributor" content="Cornelius F Boerkoel" /><meta name="DC.Date" content="2016/02/11" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1376/" /><meta name="description" content="Schimke immunoosseous dysplasia (SIOD) is an autosomal recessive multisystem disorder characterized by spondyloepiphyseal dysplasia (SED) resulting in short stature, nephropathy, and T-cell deficiency. Radiographic manifestations of SED include ovoid and mildly flattened vertebral bodies, small deformed capital femoral epiphyses, and shallow dysplastic acetabular fossae. Adult height is 136-157 cm for men and 98.5-143 cm for women. Nearly all affected individuals have progressive steroid-resistant nephropathy, usually developing within five years of the diagnosis of growth failure and terminating with end-stage renal disease (ESRD). The majority of tested individuals have T-cell deficiency and an associated risk for opportunistic infection, a common cause of death. SIOD involves a spectrum that ranges from an infantile or severe early-onset form with death early in life to a juvenile or milder later-onset form with survival into adulthood if renal disease is appropriately treated." /><meta name="og:title" content="Schimke Immunoosseous Dysplasia" /><meta name="og:type" content="book" /><meta name="og:description" content="Schimke immunoosseous dysplasia (SIOD) is an autosomal recessive multisystem disorder characterized by spondyloepiphyseal dysplasia (SED) resulting in short stature, nephropathy, and T-cell deficiency. Radiographic manifestations of SED include ovoid and mildly flattened vertebral bodies, small deformed capital femoral epiphyses, and shallow dysplastic acetabular fossae. Adult height is 136-157 cm for men and 98.5-143 cm for women. Nearly all affected individuals have progressive steroid-resistant nephropathy, usually developing within five years of the diagnosis of growth failure and terminating with end-stage renal disease (ESRD). The majority of tested individuals have T-cell deficiency and an associated risk for opportunistic infection, a common cause of death. SIOD involves a spectrum that ranges from an infantile or severe early-onset form with death early in life to a juvenile or milder later-onset form with survival into adulthood if renal disease is appropriately treated." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1376/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/siod/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1376/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D69A8E040458100000000084402F2.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1376_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1376_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/salih-myo/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/schmid-mcd/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1376_"><span class="title" itemprop="name">Schimke Immunoosseous Dysplasia</span></h1><p class="contrib-group"><span itemprop="author">Marie Morimoto</span>, BSc, <span itemprop="author">David B Lewis</span>, MD, <span itemprop="author">Thomas L&#x000fc;cke</span>, MD, PhD, and <span itemprop="author">Cornelius F Boerkoel</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1376_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1376_ai__"><div class="contrib half_rhythm"><span itemprop="author">Marie Morimoto</span>, BSc<div class="affiliation small">Department of Medical Genetics<br />University of British Columbia<br />Vancouver, British Columbia, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.irfc@otomiromm" class="oemail">ac.irfc@otomiromm</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">David B Lewis</span>, MD<div class="affiliation small">Department of Pediatrics<br />Division of Allergy, Immunology, and Rheumatology<br />Stanford University School of Medicine<br />Stanford, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.drofnats@siwelbd" class="oemail">ude.drofnats@siwelbd</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Thomas L&#x000fc;cke</span>, MD, PhD<div class="affiliation small">Department of Neuropediatrics<br />Children's Hospital<br />University of Bochum<br />Bochum, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.muhcob-inu-rhur@samoht.ekceul" class="oemail">ed.muhcob-inu-rhur@samoht.ekceul</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Cornelius F Boerkoel</span>, MD, PhD<div class="affiliation small">Department of Medical Genetics<br />University of British Columbia<br />Vancouver, British Columbia, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.irfc@leokreobn" class="oemail">ac.irfc@leokreobn</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 1, 2002</span>; Last Update: <span itemprop="dateModified">February 11, 2016</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="siod.Summary" itemprop="description"><h2 id="_siod_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Schimke immunoosseous dysplasia (SIOD) is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> multisystem disorder characterized by spondyloepiphyseal dysplasia (SED) resulting in short stature, nephropathy, and T-cell deficiency. Radiographic manifestations of SED include ovoid and mildly flattened vertebral bodies, small deformed capital femoral epiphyses, and shallow dysplastic acetabular fossae. Adult height is 136-157 cm for men and 98.5-143 cm for women. Nearly all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have progressive steroid-resistant nephropathy, usually developing within five years of the diagnosis of growth failure and terminating with end-stage renal disease (ESRD). The majority of tested individuals have T-cell deficiency and an associated risk for opportunistic infection, a common cause of death. SIOD involves a spectrum that ranges from an infantile or severe early-onset form with death early in life to a juvenile or milder later-onset form with survival into adulthood if renal disease is appropriately treated.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of SIOD is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the characteristic clinical and radiographic features. Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SMARCAL1</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> establishes the diagnosis if clinical features are inconclusive.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Renal transplantation as indicated using mild immunosuppressive therapy; hip replacement as needed in older individuals; granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor for neutropenia; bone marrow transplantation as indicated; immunosuppressive therapy for those with autoimmune manifestations; acyclovir for recurrent herpetic infections; imiquimod and cidofovir for severe disseminated cutaneous papilloma virus infections; agents that improve blood flow or decrease coagulability to treat transient ischemic attacks or strokes; standard treatment for hypothyroidism.</p><p><i>Prevention of secondary complications</i>: Vaccinations according to the protocol for other T-cell immunodeficiencies (i.e., an avoidance of live attenuated vaccines) in individuals with severe early-onset disease; prophylaxis against <i>Pneumocystis jirovecii</i> pneumonia; prophylactic acyclovir or valacylovir if recurrent oral herpetic infections or shingles occur.</p><p><i>Surveillance</i>: Regular monitoring of the hips; annual monitoring of renal, immune, and hematologic status.</p><p><i>Agents/circumstances to avoid</i>: Hypertension; heat, stress, and lack of sleep; live attenuated immunizations in those who are T-cell deficient; DNA damaging anti-cancer therapies.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>SIOD is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing and prenatal testing are possible if both pathogenic variants in the family are known.</p></div></div><div id="siod.Diagnosis"><h2 id="_siod_Diagnosis_">Diagnosis</h2><div id="siod.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Schimke immunoosseous dysplasia (SIOD) <b>should be suspected</b> in individuals with the following:</p><ul><li class="half_rhythm"><div><b>Short stature</b> (99% of individuals) that typically manifests as a short neck and trunk with lumbar lordosis and a protruding abdomen</div></li><li class="half_rhythm"><div><b>Spondyloepiphyseal dysplasia</b> (75%). The most commonly observed radiologic abnormalities are ovoid and mildly flattened vertebral bodies, small deformed capital femoral epiphyses, and shallow dysplastic acetabular fossae. Other bony abnormalities are less common.</div></li><li class="half_rhythm"><div><b>Progressive steroid-resistant nephropathy.</b> Almost all (99%) individuals with SIOD have proteinuria; this generally evolves into ESRD. The renal pathology has been reported as focal segmental glomerulosclerosis without pathognomonic features in 83% of individuals.</div></li><li class="half_rhythm"><div><b>T-cell deficiency</b> (76% of tested individuals). In general, both CD4 and CD8 cells are reduced and the CD4/CD8 ratio is normal. The T cells are predominantly of a memory (CD45R0+CD45RA-) surface <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</div></li><li class="half_rhythm"><div><b>Characteristic facial features</b> that include a wide, depressed nasal bridge (65%) and a broad nasal tip (78%)</div></li><li class="half_rhythm"><div><b>Hyperpigmented macules</b> (70%) on the trunk and occasionally extending onto the arms, neck, and legs</div></li></ul></div><div id="siod.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of SIOD <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the above clinical features. Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SMARCAL1</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1376/table/siod.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figsiodTmoleculargenetictestingusedin" rid-ob="figobsiodTmoleculargenetictestingusedin">Table 1</a>) confirms the diagnosis if clinical features are inconclusive.</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>SMARCAL1</i> is performed first followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SMARCAL1</i> and other genes of interest (see <a href="#siod.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>, and mitochondrial sequencing may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) fails to confirm a diagnosis in an individual with features of SIOD. For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="siod.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Schimke Immunoosseous Dysplasia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1376/table/siod.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__siod.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_siod.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_siod.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_siod.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_siod.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMARCAL1</i></td><td headers="hd_h_siod.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_siod.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~90%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_siod.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_siod.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 individual&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_siod.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td><td headers="hd_h_siod.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_siod.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="siod.TF.1.1"><p class="no_margin">See <a href="/books/NBK1376/#siod.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="siod.TF.1.2"><p class="no_margin">See <a href="#siod.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="siod.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="siod.TF.1.4"><p class="no_margin">Of individuals diagnosed with SIOD based on co-occurrence of spondyloepiphyseal dysplasia, renal failure, T-cell deficiency and typical facial features</p></div></dd><dt>5. </dt><dd><div id="siod.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="siod.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#siod.REF.boerkoel.2002.215">Boerkoel et al [2002]</a>; Author, personal observation</p></div></dd><dt>7. </dt><dd><div id="siod.TF.1.7"><p class="no_margin">The presence of individuals with clinical features of SIOD who do not have identifiable pathogenic variants in <i>SMARCAL1</i> [<a class="bk_pop" href="#siod.REF.clewing.2007b.273">Clewing et al 2007b</a>] suggests that pathogenic variants in other, as-yet unidentified genes can also cause SIOD.</p></div></dd></dl></div></div></div></div></div><div id="siod.Clinical_Characteristics"><h2 id="_siod_Clinical_Characteristics_">Clinical Characteristics</h2><div id="siod.Clinical_Description"><h3>Clinical Description</h3><p>Schimke immunoosseous dysplasia (SIOD) is a multisystem progressive disorder. <a class="figpopup" href="/books/NBK1376/table/siod.T.frequency_of_physical_radiographi/?report=objectonly" target="object" rid-figpopup="figsiodTfrequencyofphysicalradiographi" rid-ob="figobsiodTfrequencyofphysicalradiographi">Table 2</a> indicates the frequency of clinical findings in this condition based on published reports.</p><div id="siod.T.frequency_of_physical_radiographi" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Frequency of Physical, Radiographic, and Laboratory Features in Individuals with Schimke Immunoosseous Dysplasia Confirmed on Molecular Testing</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1376/table/siod.T.frequency_of_physical_radiographi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__siod.T.frequency_of_physical_radiographi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Feature</th><th id="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Number of Affected Individuals with Feature</th><th id="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Total Individuals with SIOD&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Growth</b></td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">IUGR&#x000a0;<sup>2</sup></td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">58 (70%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">83</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Short stature</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">82 (99%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">83</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="6" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Skeletal features</b></td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Short neck</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">66 (86%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">77</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Short trunk</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">68 (85%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">80</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Lumbar lordosis</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">57 (74%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">77</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Ovoid flat vertebrae</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">54 (77%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">70</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Hypoplastic pelvis</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">44 (65%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">68</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Abnormal femoral heads</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">64 (89%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">72</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Renal disease</b></td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proteinuria or nephropathy</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">84 (99%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">85</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">FSGS</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">43 (83%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">52</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hematologic abnormalities</b></td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">T-cell deficiency</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">47 (76%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">62</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Lymphopenia</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">58 (74%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">78</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Neutropenia</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">27 (38%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">71</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Thrombocytopenia</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19 (25%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">77</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Anemia</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">43 (57%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">75</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="7" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Physical features</b></td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Broad nasal tip</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">61 (78%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">78</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Wide and depressed nasal bridge</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">53 (65%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">81</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Protruding abdomen</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">59 (77%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">77</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Pigmented macules</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">57 (70%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">81</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Unusual hair</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">43 (63%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">68</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Microdontia</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">31 (53%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">59</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Corneal opacities</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11 (17%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">65</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Development</b></td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental delay</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">26 (34%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">77</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Academic delay</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10 (28%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">36</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Vasculature</b></td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Headaches</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">28 (47%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">60</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">TIAs</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">31 (41%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">76</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Strokes</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30 (43%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">69</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypothyroidism</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">24 (36%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">66</td></tr><tr><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Non-Hodgkin lymphoma&#x000a0;<sup>3</sup></td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3 (3%)</td><td headers="hd_h_siod.T.frequency_of_physical_radiographi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">86</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">FSGS = focal segmental glomerulosclerosis; UGR = intrauterine growth retardation; TIAs = transient ischemic attacks</p></div></dd><dt>1. </dt><dd><div id="siod.TF.2.1"><p class="no_margin">Total individuals with SIOD for whom the feature of interest has been reported to be present or absent</p></div></dd><dt>2. </dt><dd><div id="siod.TF.2.2"><p class="no_margin">IUGR is defined as having a birth weight and/or birth length at or below the 3rd percentile for gestational age.</p></div></dd><dt>3. </dt><dd><div id="siod.TF.2.3"><p class="no_margin">EBV-positive and EBV-negative non-Hodgkin lymphoma</p></div></dd></dl></div></div></div><p><b>Growth.</b> Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children have prenatal and postnatal disproportionate growth failure. A few have normal intrauterine growth followed by postnatal growth failure. The observed disproportionate growth deficiency is not a result of renal failure. Comparison of the anthropometric measurements of persons with SIOD to persons with non-SIOD chronic kidney disease found that in nearly all parameters, persons with SIOD differed significantly from those with non-SIOD chronic renal disease. The most marked difference is that in non-SIOD chronic kidney disease, the median leg length is significantly more reduced than trunk length, while in persons with SIOD, the reduction in trunk length was significantly more than that for leg length. Therefore, a sitting height/leg-length ratio of less than 0.83 is suggestive of SIOD in persons with chronic kidney disease [<a class="bk_pop" href="#siod.REF.l_cke.2006a.e400">L&#x000fc;cke et al 2006a</a>].</p><p>The mean age of diagnosis with growth failure was two years (range: age 0-13 years) [<a class="bk_pop" href="#siod.REF.clewing.2007b.273">Clewing et al 2007b</a>]. Generally, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a normal growth hormone axis and no response to growth hormone supplementation. Height in those who have survived to adulthood is 136-157 cm for men and 98.5-143 cm for women.</p><p><b>Skeletal features.</b> In addition to the prominent vertebral and femoral abnormalities, less frequent skeletal problems include a widened sella turcica, thoracic kyphosis, scoliosis, and osteopenia. Affected individuals do not usually have joint pain until they develop degenerative hip disease.</p><p><b>Renal disease.</b> Nephropathy usually develops before age 12 years and progresses to ESRD within the subsequent one to 11 years. Usually the diagnosis of nephropathy is made concurrent with or within the five years following the diagnosis of growth failure. Focal segmental glomerulosclerosis (FSGS) is the predominant renal pathology in individuals with SIOD. The FSGS of SIOD is associated with a significant increase in expression of the NOTCH receptors and ligands in the renal glomeruli [<a class="bk_pop" href="#siod.REF.morimoto">Morimoto et al, submitted</a>]. Increased NOTCH signaling is a known cause of FSGS [<a class="bk_pop" href="#siod.REF.niranjan.2008.290">Niranjan et al 2008</a>, <a class="bk_pop" href="#siod.REF.murea.2010.514">Murea et al 2010</a>].</p><p><b>Hematologic abnormalities.</b> T-cell deficiency causes lymphopenia in approximately 80% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Those T cells that are present are predominantly of a memory (CD45R0+) rather than a na&#x000ef;ve (CD45RA+) surface <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, consistent with reduced production of T cells by the thymus [<a class="bk_pop" href="#siod.REF.sanyal.2015.355">Sanyal et al 2015</a>]. The B-cell count is usually normal to slightly elevated. In addition to T-cell deficiency, several individuals with SIOD have had deficiencies of other blood cell lineages. See <a class="figpopup" href="/books/NBK1376/table/siod.T.frequency_of_physical_radiographi/?report=objectonly" target="object" rid-figpopup="figsiodTfrequencyofphysicalradiographi" rid-ob="figobsiodTfrequencyofphysicalradiographi">Table 2</a> for types and frequency. The T-cell deficiency is associated with a lack of interleukin 7 receptor alpha expression on the T cells of patients with SIOD [<a class="bk_pop" href="#siod.REF.sanyal.2015.355">Sanyal et al 2015</a>]. This receptor is critical for T-cell development and has been previously implicated in severe combined immunodeficiency [<a class="bk_pop" href="#siod.REF.puel.1998.394">Puel et al 1998</a>, <a class="bk_pop" href="#siod.REF.roifman.2000.2803">Roifman et al 2000</a>].</p><p>Immunodeficiency increases the risk of opportunistic infections such as <i>Pneumocystis jiroveciii</i> pneumonia. More than half of individuals with SIOD have recurrent infections with various bacteria, viruses (including herpes simplex virus, varicella-zoster virus, cytomegalovirus), and fungi (e.g., oral and/or cutaneous candida) [<a class="bk_pop" href="#siod.REF.boerkoel.2000.1">Boerkoel et al 2000</a>, <a class="bk_pop" href="#siod.REF.boerkoel.2002.215">Boerkoel et al 2002</a>]. Infection is a common cause of death.</p><p>About 20% of individuals with SIOD have features of autoimmune disease. These manifestations include immune thrombocytopenia, hemolytic anemia, enteropathy, pericarditis with anti-cardiolipin antibodies, and Evans syndrome (a combination of hemolytic anemia and immune thrombocytopenia) [<a class="bk_pop" href="#siod.REF.zieg.2011.27">Zieg et al 2011</a>].</p><p><b>Physical features.</b> Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have hyperpigmented macules on the trunk and occasionally on the extremities, neck, and face. Less common ectodermal abnormalities include fine and/or sparse hair; 66% have had microdontia, hypodontia and/or malformed deciduous and permanent molars [<a class="bk_pop" href="#siod.REF.morimoto.2012a.29s">Morimoto et al 2012a</a>], and corneal opacities.</p><p><b>Development.</b> Most individuals with SIOD have normal intellectual and neurologic development until the onset of cerebral ischemic events. A few have developmental delay; in most of these, the delay can be ascribed to the deleterious consequences of chronic illness and/or early recurrent cerebral ischemic events.</p><p><b>Central nervous system (CNS) symptoms, atherosclerosis and hypertension.</b> Nearly half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have severe migraine-like headaches, transient neurologic attacks (TNAs), or ischemic events [<a class="bk_pop" href="#siod.REF.kilic.2005.206">Kilic et al 2005</a>]. The TNAs are usually focal and generally do not have an ischemic origin. Some affected individuals also have heat intolerance and develop CNS symptoms during hot weather [<a class="bk_pop" href="#siod.REF.baradaranheravi.2012a.2572">Baradaran-Heravi et al 2012a</a>]. Generally, those with transient ischemic attacks or strokes have diffuse, progressive cerebral arteriosclerosis, whereas those with only migraine-like headaches do not. Frequently the cerebral ischemic events are precipitated by hypertension. The cause of the severe migraine-like headaches is unknown.</p><p>Half of individuals with SIOD have symptoms suggestive of atherosclerosis. Vascular changes observed on postmortem tissue from three individuals included focal intimal lipid deposition, focal myointimal proliferation, macrophage invasion, foam cells, fibrous transformation, and calcium deposits [<a class="bk_pop" href="#siod.REF.spranger.1991.64">Spranger et al 1991</a>, <a class="bk_pop" href="#siod.REF.l_cke.2004.672">L&#x000fc;cke et al 2004</a>, <a class="bk_pop" href="#siod.REF.clewing.2007a.122">Clewing et al 2007a</a>]. The pulmonary and systemic hypertension that persisted despite renal transplantation described by <a class="bk_pop" href="#siod.REF.l_cke.2004.672">L&#x000fc;cke et al [2004]</a> could be explained by myointimal hyperplasia [<a class="bk_pop" href="#siod.REF.clewing.2007a.122">Clewing et al 2007a</a>].</p><p>Also, <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression studies have identified a significant decrease in the expression of <i>ELN</i> in individuals with SIOD [<a class="bk_pop" href="#siod.REF.morimoto.2012b.70">Morimoto et al 2012b</a>]<i>.</i> This gene encodes for the precursor to elastin protein, which is critical for maintaining the integrity of the arterial wall. Histopathologic analysis of postmortem arterial tissue from three individuals with SIOD showed splitting and fragmentation of elastin fibers [<a class="bk_pop" href="#siod.REF.clewing.2007a.122">Clewing et al 2007a</a>, <a class="bk_pop" href="#siod.REF.morimoto.2012b.70">Morimoto et al 2012b</a>]. Reduction in the elastin protein results in the increased proliferation of smooth muscle cells in arterial walls and leads to intimal hyperplasia [<a class="bk_pop" href="#siod.REF.urb_n.2002.30">Urb&#x000e1;n et al 2002</a>]. The reduction in elastin expression in the SIOD aorta appears to arise from reduced transcription of <i>ELN</i> as well as increased post-transcriptional <i>ELN</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> decay [<a class="bk_pop" href="#siod.REF.morimoto.2015.609">Morimoto et al 2015</a>].</p><p><b>Hypothyroidism.</b> A third of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have subclinical hypothyroidism that persists after renal transplantation. The concentration of thyroid stimulating hormone (TSH) is increased and free and total T3 and T4 concentrations are reduced.</p><p><b>Gastrointestinal findings.</b> A few individuals with SIOD have enteropathy. In most of these individuals, the enteropathy results from infection (e.g., <i>Helicobacter pylori</i>). However, one individual without evidence of infection had gastrointestinal villous atrophy that improved with corticosteroid therapy [<a class="bk_pop" href="#siod.REF.kaitila.1998.427">Kaitila et al 1998</a>].</p><p><b>Clinical course and outcome.</b> SIOD varies in severity, ranging from <i>in utero</i> onset of growth retardation with death in the first few years of life to a slowly progressive course with survival into adulthood. Classically, SIOD has been divided into an infantile- or severe early-onset form and a juvenile- or milder later-onset form. SIOD follows a continuum such that <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with early-onset and severe symptoms usually die early in life, whereas those with mild symptoms survive into adulthood if ESRD is treated with renal dialysis and/or renal transplantation. Severity and age of onset of symptoms do not, however, invariably predict survival; a few individuals have survived beyond age 20 years despite having relatively severe early-onset disease [<a class="bk_pop" href="#siod.REF.lou.2002.922">Lou et al 2002</a>, <a class="bk_pop" href="#siod.REF.l_cke.2004.672">L&#x000fc;cke et al 2004</a>].</p><p>Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals develop other symptoms within one to five years of the diagnosis of growth failure. Those with severe symptoms usually die within four to eight years. The mean age of death is 11 years. Causes of death include infection (23%), stroke (13%), pulmonary hypertension and congestive heart failure (13%), renal failure (11%), complications of organ transplantation (9%), lymphoproliferative disease (4%), gastrointestinal complications (4%), respiratory failure (4%), bone marrow failure (2%), non-Hodgkin lymphoma (2%), pancreatitis (2%), and other causes not reported (13%).</p><p>Among those who have survived beyond puberty, none has reproduced yet. Women develop menses, although the menstrual cycle is usually irregular. Men develop secondary sexual characteristics, but histopathologic examination of the testes identified azoospermia [<a class="bk_pop" href="#siod.REF.clewing.2007a.122">Clewing et al 2007a</a>].</p></div><div id="siod.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Ongoing correlations of <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> to <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> have shown that genotype does not predict disease severity or outcome either within or among families [<a class="bk_pop" href="#siod.REF.b_kenkamp.2005.1724">B&#x000f6;kenkamp et al 2005</a>, <a class="bk_pop" href="#siod.REF.l_cke.2005a.202">L&#x000fc;cke et al 2005a</a>, <a class="bk_pop" href="#siod.REF.clewing.2007b.273">Clewing et al 2007b</a>, <a class="bk_pop" href="#siod.REF.dekel.2008.398">Dekel et al 2008</a>, <a class="bk_pop" href="#siod.REF.baradaranheravi.2012a.2572">Baradaran-Heravi et al 2012a</a>]. The phenotypic heterogeneity and <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> suggest that SIOD is modified by factors such as environment, epigenetics, and <a class="def" href="/books/n/gene/glossary/def-item/oligogenic/">oligogenic</a> inheritance.</p><p>In five multiplex families, the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of sibs has been variable:</p><ul><li class="half_rhythm"><div>A boy succumbed to a stroke at age 3.7 years after developing ESRD; his sister succumbed to bone marrow failure at age 2.75 years before developing renal failure and without symptoms of cerebral ischemia [<a class="bk_pop" href="#siod.REF.lou.2002.922">Lou et al 2002</a>].</div></li><li class="half_rhythm"><div>Of two brothers, one had severe disease and the other had relatively mild disease [<a class="bk_pop" href="#siod.REF.l_cke.2005a.202">L&#x000fc;cke et al 2005a</a>].</div></li><li class="half_rhythm"><div>Of two brothers with <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <i>SMARCAL1</i> pathogenic variants, one presented with growth failure at age six years [<a class="bk_pop" href="#siod.REF.b_kenkamp.2005.1724">B&#x000f6;kenkamp et al 2005</a>], while the other had normal growth at age ten years [unpublished data].</div></li><li class="half_rhythm"><div>Of three sibs reported by <a class="bk_pop" href="#siod.REF.lama.1995.19">Lama et al [1995]</a>, one died as a child with severe disease, one had normal stature and died of a pulmonary infection at 43 years, and one has survived into the fourth decade.</div></li><li class="half_rhythm"><div>Of three sibs reported by <a class="bk_pop" href="#siod.REF.dekel.2008.398">Dekel et al [2008]</a> the elder brother demonstrated severe disease from age 3.5 years and two younger non-identical twin brothers had relatively mild disease.</div></li></ul><p>As a group, those individuals with prominent features of SIOD without detectable <i>SMARCAL1</i> pathogenic variants have a lower frequency of hyperpigmented macules, lymphopenia, focal segmental glomerulosclerosis, and cerebral ischemic symptoms and a higher frequency of cognitive impairment [<a class="bk_pop" href="#siod.REF.clewing.2007b.273">Clewing et al 2007b</a>, <a class="bk_pop" href="#siod.REF.baradaranheravi.2008.2013">Baradaran-Heravi et al 2008</a>].</p></div><div id="siod.Nomenclature"><h3>Nomenclature</h3><p><a class="bk_pop" href="#siod.REF.ehrich.1990.117">Ehrich et al [1990]</a> contributed to the clinical description of the disease; thus, in parts of Germany the term "morbus Ehrich" has also been used.</p></div><div id="siod.Prevalence"><h3>Prevalence</h3><p>The prevalence is unknown. However, based on referrals and published birth rates, the incidence in North America is estimated at 1:1,000,000 to 1:3,000,000 live births [Author, personal observation].</p><p>SIOD is pan ethnic.</p></div></div><div id="siod.Genetically_Related_Allelic_Disorde"><h2 id="_siod_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>SMARCAL1</i>.</p></div><div id="siod.Differential_Diagnosis"><h2 id="_siod_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of Schimke immunoosseous dysplasia (SIOD) depends on the presenting features of the individual. <a class="figpopup" href="/books/NBK1376/table/siod.T.hereditary_osteochondrodysplasias/?report=objectonly" target="object" rid-figpopup="figsiodThereditaryosteochondrodysplasias" rid-ob="figobsiodThereditaryosteochondrodysplasias">Table 3</a> lists those hereditary osteochondrodysplasias associated with nephrotic syndrome or immune defects.</p><div id="siod.T.hereditary_osteochondrodysplasias" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Hereditary Osteochondrodysplasias Associated with Nephrotic Syndrome or Immune Defects</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1376/table/siod.T.hereditary_osteochondrodysplasias/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__siod.T.hereditary_osteochondrodysplasias_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Syndrome (OMIM)</th><th id="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Immune Cell Defect</th><th id="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th></tr></thead><tbody><tr><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Associated</b><br /><b>w/nephrotic</b><br /><b>syndrome</b></td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Conorenal syndrome (<a href="http://omim.org/entry/266920" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">266920</a>)</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IFT140</i></td></tr><tr><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/nail-ps/">Nail-patella syndrome</a></td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LMX1B</i></td></tr><tr><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Schimke immunoosseous dysplasia</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">T cell</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMARCAL1</i></td></tr><tr><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" rowspan="9" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Associated</b><br /><b>w/immune</b><br /><b>defects</b></td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Short-limb skeletal dysplasia with severe combined immunodeficiency (<a href="http://omim.org/entry/200900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">200900</a>)</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">T &#x00026; B cells</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/chh/">Cartilage-hair hypoplasia</a></td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">T &#x00026; B cells</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RMRP</i></td></tr><tr><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Short-limb skeletal dysplasia with humoral immunodeficiency&#x000a0;<sup>1</sup></td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">B cell</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Roifman syndrome (<a href="http://omim.org/entry/616651" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616651</a>)</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">B cell</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RNU4ATAC</i></td></tr><tr><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Kenny-Caffey syndrome, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> (<a href="http://omim.org/entry/244460" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">244460</a>)</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">T cell</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TBCE</i></td></tr><tr><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sanjad-Sakati syndrome (<a href="http://omim.org/entry/241410" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">241410</a>)</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">T cell</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TBCE</i></td></tr><tr><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Immunodeficiency-centromeric instability-facial anomalies syndrome (<a href="http://omim.org/entry/242860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">242860</a>)</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">B cell</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DNMT3B</i></td></tr><tr><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Spondylomesomelic acrodysplasia&#x000a0;<sup>2</sup></td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">T &#x00026; B cells</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Ramanan syndrome&#x000a0;<sup>3</sup></td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">T &#x00026; B cells</td><td headers="hd_h_siod.T.hereditary_osteochondrodysplasias_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="siod.TF.3.1"><p class="no_margin"><a class="bk_pop" href="#siod.REF.ammann.1974.200">Ammann et al [1974]</a></p></div></dd><dt>2. </dt><dd><div id="siod.TF.3.2"><p class="no_margin"><a class="bk_pop" href="#siod.REF.castriotascanderbeg.1997.854">Castriota-Scanderbeg et al [1997]</a></p></div></dd><dt>3. </dt><dd><div id="siod.TF.3.3"><p class="no_margin"><a class="bk_pop" href="#siod.REF.ramanan.2000.173">Ramanan et al [2000]</a></p></div></dd></dl></div></div></div><p>The co-occurrence of T-cell deficiency, disproportionate short stature with spondyloepiphyseal dysplasia, and progressive nephropathy is unique to SIOD.</p><p>Short stature resulting from renal failure can be distinguished from that of SIOD by the disproportion in body measures [<a class="bk_pop" href="#siod.REF.l_cke.2006a.e400">L&#x000fc;cke et al 2006a</a>]. Among individuals with chronic renal failure, median leg length was significantly more reduced than sitting height, whereas in individuals with SIOD, the reduction of sitting height was significantly more pronounced than for leg length. SIOD is very likely if this ratio is less than 0.83. However, other forms of chronic kidney disease have to be considered if the ratio is greater than 1.01.</p></div><div id="siod.Management"><h2 id="_siod_Management_">Management</h2><div id="siod.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Schimke immunoosseous dysplasia (SIOD), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Measurement of growth and assessment of body proportions, with plotting on age-appropriate growth charts [<a class="bk_pop" href="#siod.REF.l_cke.2006a.e400">L&#x000fc;cke et al 2006a</a>]</div></li><li class="half_rhythm"><div>Evaluation of renal function by measurement of serum concentrations of creatinine and urea, protein excretion in urine, and creatinine clearance</div></li><li class="half_rhythm"><div>Referral to a nephrologist for evaluation</div></li><li class="half_rhythm"><div>Hematology evaluations to assess lymphopenia, anemia, neutropenia, and thrombocytopenia</div></li><li class="half_rhythm"><div>Immunology evaluations to evaluate the numbers of memory and na&#x000ef;ve CD4 and CD8 T cells and B cells and immunoglobulin levels</div></li><li class="half_rhythm"><div>Assessment of developmental status with referral for formal evaluation if significant developmental delays or schooling delays are identified</div></li><li class="half_rhythm"><div>Dental evaluation after teeth are present</div></li><li class="half_rhythm"><div>Ophthalmologic evaluation</div></li><li class="half_rhythm"><div>Detailed history for headaches or neurologic abnormalities</div></li><li class="half_rhythm"><div>Orthopedic evaluation for symptoms of joint pain or evidence of scoliosis or kyphosis</div></li><li class="half_rhythm"><div>Assessment for osteopenia</div></li><li class="half_rhythm"><div>Thyroid function studies</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="siod.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Renal manifestations</b></p><ul><li class="half_rhythm"><div>The renal disease progresses from proteinuria to ESRD at variable rates and is not prevented by any known drug therapies, although a few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals treated with cyclosporin A, tacrolimus, or corticosteroids have had a transient reduction in the rate of renal disease progression.</div></li><li class="half_rhythm"><div>Renal transplantation effectively treats the nephropathy and neither nephropathy nor arteriosclerosis recurs in the graft [<a class="bk_pop" href="#siod.REF.l_cke.2004.672">L&#x000fc;cke et al 2004</a>, <a class="bk_pop" href="#siod.REF.elizondo.2006.340">Elizondo et al 2006</a>, <a class="bk_pop" href="#siod.REF.clewing.2007a.122">Clewing et al 2007a</a>]. Mild immunosuppressive therapy, such as immunosuppressive monotherapy, appears to improve outcome after renal transplantation [<a class="bk_pop" href="#siod.REF.l_cke.2009.482">L&#x000fc;cke et al 2009</a>].</div></li></ul><p><b>Orthopedic manifestations</b></p><ul><li class="half_rhythm"><div>Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have survived beyond childhood have required hip replacement.</div></li><li class="half_rhythm"><div>Treatment of scoliosis and/or kyphosis is standard.</div></li></ul><p><b>Immunologic manifestations</b></p><ul><li class="half_rhythm"><div>Neutropenia usually responds well to supplementation with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor.</div></li><li class="half_rhythm"><div>One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has been successfully treated by bone marrow transplantation (BMT) [<a class="bk_pop" href="#siod.REF.petty.2000.882">Petty et al 2000</a>, <a class="bk_pop" href="#siod.REF.thomas.2004.507">Thomas et al 2004</a>], and four affected individuals have died after BMT [<a class="bk_pop" href="#siod.REF.baradaranheravi.2013.2609">Baradaran-Heravi et al 2013</a>].</div></li><li class="half_rhythm"><div>Individuals with autoimmune problems have had variable responses to treatment.</div><ul><li class="half_rhythm"><div>A few individuals have been transfusion dependent because of anemia or thrombocytopenia.</div></li><li class="half_rhythm"><div>In one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with thrombocytopenia, the autoimmune features resolved spontaneously; in one they resolved after steroid and IVIG treatments, and in one they cleared after splenectomy. All other affected individuals, excepting one with Evans syndrome, were successfully treated with immunosuppressive therapy such as steroids, cyclophosphamide, or IVIG. The individual with Evans syndrome was resistant to treatment with steroids, cyclosporin A, and rituximab [<a class="bk_pop" href="#siod.REF.zieg.2011.27">Zieg et al 2011</a>].</div></li></ul></li></ul><p><b>Infectious disease manifestations.</b> Individuals with recurrent infections, opportunistic infections, or declining lymphocytes or T-cell counts frequently require the care of an immunologist.</p><ul><li class="half_rhythm"><div>Affected individuals with recurrent herpetic infections benefit from treatment with acyclovir.</div></li><li class="half_rhythm"><div>A few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have developed severe disseminated cutaneous papilloma virus infections that have improved with imiquimod and cidofovir.</div></li></ul><p><b>Neurologic manifestations</b></p><ul><li class="half_rhythm"><div>Individuals with transient ischemic attacks or strokes usually show temporary improvement on treatment with agents that improve blood flow or decrease coagulability (pentoxifylline, acetylsalicylic acid, dipyridamole, warfarin, heparin). To date, no curative or effective long-term therapies have been identified.</div></li><li class="half_rhythm"><div>Migraine headaches are often difficult to treat since response to anti-migraine medication is variable. Medications that have helped some individuals include ergotamine, sumatriptan, verapamil, and propranolol. Note: Use of ergotamine and sumatriptan is contraindicated in individuals with SIOD with severe vasoocclusive disease or cerebral ischemic events.</div></li></ul><p><b>Hypothyroidism</b> can be treated with levothyroxine supplementation; however, supplementation does not have an ameliorative effect on the renal disease or T-cell deficiency.</p></div><div id="siod.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Individuals with severe early-onset disease are best vaccinated according to the protocol for other T-cell immunodeficiencies (i.e., only inactivated vaccines should be used with avoidance of all live-attenuated vaccines).</p><p>Because of the increased risk of opportunistic infection, prophylaxis (trimethoprim/sulfamethoxazole or atovquone) against <i>Pneumocystis jirovecii</i> pneumonia is usually recommended.</p><p>If recurrent oral herpetic infections or shingles occur, prophylactic acyclovir may reduce the morbidity.</p></div><div id="siod.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Regular monitoring of the hips</div></li><li class="half_rhythm"><div>Annual monitoring of renal, immune, and hematologic status</div></li></ul></div><div id="siod.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p><b>Hypertension.</b> Poor blood pressure control can exacerbate or evoke cerebral ischemia. In particular, the hypertension arising from using high-dose steroids for empiric treatment of the nephrotic syndrome can evoke cerebral ischemia.</p><p><b>Heat, stress, and lack of sleep.</b> Individuals with transient neurologic attacks that are not of an ischemic origin have found that heat, stress, and lack of sleep can precipitate the attacks.</p><p><b>Vaccinations with live vaccines.</b> The T-cell deficiency is substantial and there have been serious infections in some individuals. Therefore, vaccination with all live vaccines should be avoided, including rotavirus, MMR, varicella, BCG, oral Salmonella typhi vaccine, and yellow fever virus vaccine.</p><p><b>Anti-cancer therapies.</b> SIOD cells and model organisms are hypersensitive to DNA damaging agents [<a class="bk_pop" href="#siod.REF.bansbach.2009.2405">Bansbach et al 2009</a>, <a class="bk_pop" href="#siod.REF.ciccia.2009.2415">Ciccia et al 2009</a>, <a class="bk_pop" href="#siod.REF.postow.2009.35951">Postow et al 2009</a>, <a class="bk_pop" href="#siod.REF.yuan.2009.2394">Yuan et al 2009</a>, <a class="bk_pop" href="#siod.REF.yusufzai.2009.2400">Yusufzai et al 2009</a>, <a class="bk_pop" href="#siod.REF.bansbach.2010.245">Bansbach et al 2010</a>, <a class="bk_pop" href="#siod.REF.baradaranheravi.2012b.2204">Baradaran-Heravi et al 2012b</a>].</p></div><div id="siod.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate (see <a href="#siod.Diagnosis">Diagnosis</a>) older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify as early as possible those who would benefit from surveillance and preventive measures.</p><p>See <a href="#siod.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="siod.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Combined renal and bone marrow transplantation may be discussed as an approach in individuals with declining renal and immune function prior to the onset of end-stage disease.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="siod.Other"><h3>Other</h3><p>Individuals with SIOD usually have normal growth hormone studies. No <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual treated with growth hormone supplementation has responded with improved growth.</p><p>Anemia does not often respond to supplementation with erythropoietin or renal transplantation. However, it is possible that erythropoietin has a protective effect on the endothelia.</p><p>Because of the T-cell defect, individuals with SIOD usually require milder immunosuppressive therapy for bone marrow transplantation than those undergoing transplantation for other diseases.</p><p>Studies of mitochondrial function and nitrous oxide production have not detected any impairment; therefore, empiric treatments addressing such etiologies would be expected to have little effect [<a class="bk_pop" href="#siod.REF.l_cke.2005b.237">L&#x000fc;cke et al 2005b</a>, <a class="bk_pop" href="#siod.REF.l_cke.2006b.678">L&#x000fc;cke et al 2006b</a>].</p></div></div><div id="siod.Genetic_Counseling"><h2 id="_siod_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="siod.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Schimke immunoosseous dysplasia (SIOD) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="siod.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>SMARCAL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of inheriting <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SMARCAL1</i> pathogenic variants and being at risk of developing SIOD, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Sibs with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SMARCAL1</i> pathogenic variants can have variable phenotypes (see <a href="#siod.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> To date, individuals with SIOD are not known to reproduce.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>SMARCAL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="siod.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>SMARCAL1</i> pathogenic variants in the family.</p></div><div id="siod.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="siod.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>SMARCAL1</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for SIOD are possible.</p><p><b>Ultrasound examination.</b> The diagnosis may be suspected in a fetus with intrauterine growth retardation and an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sib.</p></div></div><div id="siod.Resources"><h2 id="_siod_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Human Growth Foundation (HGF)</b></div><div>997 Glen Cove Avenue</div><div>Suite 5</div><div>Glen Head NY 11545</div><div><b>Phone:</b> 800-451-6434 (toll-free)</div><div><b>Fax:</b> 516-671-4055</div><div><b>Email:</b> hgf1@hgfound.org</div><div><a href="http://www.hgfound.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hgfound.org</a></div></li><li class="half_rhythm"><div><b>Little People of America, Inc. (LPA)</b></div><div>250 El Camino Real</div><div>Suite 201</div><div>Tustin CA 92780</div><div><b>Phone:</b> 888-572-2001 (toll-free); 714-368-3689</div><div><b>Fax:</b> 714-368-3367</div><div><b>Email:</b> info@lpaonline.org</div><div><a href="http://www.lpaonline.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.lpaonline.org</a></div></li><li class="half_rhythm"><div><b>MAGIC Foundation</b></div><div>4200 Cantera Drive #106</div><div>Warrenville IL 60555</div><div><b>Phone:</b> 800-362-4423 (Toll-free Parent Help Line); 630-836-8200</div><div><b>Fax:</b> 630-836-8181</div><div><b>Email:</b> contactus@magicfoundation.org</div><div><a href="http://www.magicfoundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.magicfoundation.org</a></div></li><li class="half_rhythm"><div><b>European Society for Immunodeficiencies (ESID) Registry</b></div><div>Dr. Gerhard Kindle</div><div>University Medical Center Freiburg Centre of Chronic Immunodeficiency</div><div>Engesserstr. 4</div><div>79106 Freiburg </div><div>Germany</div><div><b>Phone:</b> 49-761-270-34450</div><div><b>Email:</b> esid-registry@uniklinik-freiburg.de</div><div><a href="http://esid.org/Working-Parties/Registry" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ESID Registry</a></div></li><li class="half_rhythm"><div><b>International Skeletal Dysplasia Registry</b></div><div>UCLA</div><div>615 Charles E. Young Drive</div><div>South Room 410</div><div>Los Angeles CA 90095-7358</div><div><b>Phone:</b> 310-825-8998</div><div><b>Fax:</b> 310-206-5266</div><div><b>Email:</b> Salon@mednet.ucla.edu</div><div><a href="https://www.uclahealth.org/ortho/isdr" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International Skeletal Dysplasia Registry</a></div></li></ul></div><div id="siod.Molecular_Genetics"><h2 id="_siod_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="siod.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Schimke Immunoosseous Dysplasia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1376/table/siod.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__siod.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_siod.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_siod.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_siod.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_siod.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_siod.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_siod.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_siod.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/50485" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SMARCAL1</i></a></td><td headers="hd_b_siod.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=50485" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q35</a></td><td headers="hd_b_siod.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9NZC9" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1</a></td><td headers="hd_b_siod.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SMARCAL1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMARCAL1 database</a><br /><a href="http://structure.bmc.lu.se/idbase/SMARCAL1base/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMARCAL1base: Mutation registry for Schimke immuno-osseous dysplasia</a></td><td headers="hd_b_siod.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SMARCAL1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMARCAL1</a></td><td headers="hd_b_siod.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SMARCAL1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMARCAL1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="siod.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="siod.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Schimke Immunoosseous Dysplasia (<a href="/omim/242900,606622" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1376/table/siod.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__siod.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/242900" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">242900</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SCHIMKE IMMUNOOSSEOUS DYSPLASIA; SIOD</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606622" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606622</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A-LIKE PROTEIN 1; SMARCAL1</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>SMARCAL1</i> contains 18 exons spanning approximately 70 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1376/#siod.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Normal variants of <i>SMARCAL1</i> have not been cataloed.</p><p><b>Pathogenic variants.</b> Pathogenic variants are distributed throughout <i>SMARCAL1</i>. The abnormalities reported for <i>SMARCAL1</i> are <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions eliminating expression, pathogenic truncating variants, or single-nucleotide variants. Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants occur at amino acids conserved across species.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SMARCAL1</i> encodes SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1, the SNF2-related protein most similar to the prokaryotic HepA proteins [<a class="bk_pop" href="#siod.REF.coleman.2000.274">Coleman et al 2000</a>]. SNF2-related proteins participate in the DNA-nucleosome restructuring that commonly occurs during gene regulation and DNA replication, <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a>, <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a>, repair, and transcription [<a class="bk_pop" href="#siod.REF.pazin.1997.737">Pazin &#x00026; Kadonaga 1997</a>, <a class="bk_pop" href="#siod.REF.havas.2001.673">Havas et al 2001</a>]. The <i>SMARCAL1</i> protein product is known as HARP or SMARCAL1. HARP binds DNA at single-to-double strand transitions and hydrolyzes ATP [<a class="bk_pop" href="#siod.REF.muthuswami.2000.7648">Muthuswami et al 2000</a>] to produce energy to re-anneal open strands of DNA [<a class="bk_pop" href="#siod.REF.yusufzai.2008.748">Yusufzai &#x00026; Kadonaga 2008</a>]. Such DNA structures are commonly seen during DNA replication and repair and transcription. At these sites, HARP re-anneals the single-stranded DNA, thereby preventing DNA damage. Consequently, HARP deficiency leads to increased DNA damage and hypersensitivity to DNA-damaging agents [<a class="bk_pop" href="#siod.REF.bansbach.2009.2405">Bansbach et al 2009</a>, <a class="bk_pop" href="#siod.REF.ciccia.2009.2415">Ciccia et al 2009</a>, <a class="bk_pop" href="#siod.REF.postow.2009.35951">Postow et al 2009</a>, <a class="bk_pop" href="#siod.REF.yuan.2009.2394">Yuan et al 2009</a>, <a class="bk_pop" href="#siod.REF.yusufzai.2009.2400">Yusufzai et al 2009</a>, <a class="bk_pop" href="#siod.REF.baradaranheravi.2012b.2204">Baradaran-Heravi et al 2012b</a>]. Also, as a modulator of DNA structure, HARP regulates gene expression [<a class="bk_pop" href="#siod.REF.baradaranheravi.2012a.2572">Baradaran-Heravi et al 2012a</a>, <a class="bk_pop" href="#siod.REF.morimoto.2012b.70">Morimoto et al 2012b</a>]. In summary, HARP-mediated maintenance of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> integrity is required for the basic cellular processes of modulating DNA replication, DNA repair and transcription, and possibly DNA recombination.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in <i>SMARCAL1</i> are predicted to cause loss of function in HARP.</p></div><div id="siod.References"><h2 id="_siod_References_">References</h2><div id="siod.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="siod.REF.ammann.1974.200">Ammann AJ, Sutliff W, Millinchick E. Antibody-mediated immunodeficiency in short-limbed dwarfism. <span><span class="ref-journal">J Pediatr. </span>1974;<span class="ref-vol">84</span>:200–3.</span> [<a href="/pubmed/4810726" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4810726</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.bansbach.2009.2405">Bansbach CE, B&#x000e9;tous R, Lovejoy CA, Glick GG, Cortez D. The annealing helicase SMARCAL1 maintains genome integrity at stalled replication forks. <span><span class="ref-journal">Genes Dev. </span>2009;<span class="ref-vol">23</span>:2405–14.</span> [<a href="/pmc/articles/PMC2764496/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2764496</span></a>] [<a href="/pubmed/19793861" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19793861</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.bansbach.2010.245">Bansbach CE, Boerkoel CF, Cortez D. SMARCAL1 and replication stress: An explanation for SIOD? <span><span class="ref-journal">Nucleus. </span>2010;<span class="ref-vol">1</span>:245–8.</span> [<a href="/pmc/articles/PMC3027029/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3027029</span></a>] [<a href="/pubmed/21327070" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21327070</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.baradaranheravi.2012a.2572">Baradaran-Heravi A, Cho KS, Tolhuis B, Sanyal M, Morozova O, Morimoto M, Elizondo LI, Bridgewater D, Lubieniecka J, Beirnes K, Myung C, Leung D, Fam HK, Choi K, Huang Y, Dionis KY, Zonana J, Keller K, Stenzel P, Mayfield C, L&#x000fc;cke T, Bokenkamp A, Marra MA, van Lohuizen M, Lewis DB, Shaw C, Boerkoel CF. Penetrance of biallelic SMARCAL1 mutations is associated with environmental and genetic disturbances of gene expression. <span><span class="ref-journal">Hum Mol Genet. </span>2012a;<span class="ref-vol">21</span>:2572–87.</span> [<a href="/pmc/articles/PMC3349428/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3349428</span></a>] [<a href="/pubmed/22378147" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22378147</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.baradaranheravi.2013.2609">Baradaran-Heravi A, Lange J, Asakura Y, Cochat P, Massella L, Boerkoel CF. Bone marrow transplantation in Schimke immuno-osseous dysplasia. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:2609–13.</span> [<a href="/pmc/articles/PMC3788057/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3788057</span></a>] [<a href="/pubmed/23950031" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23950031</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.baradaranheravi.2012b.2204">Baradaran-Heravi A, Raams A, Lubieniecka J, Cho KS, DeHaai KA, Basiratnia M, Mari PO, Xue Y, Rauth M, Olney AH, Shago M, Choi K, Weksberg RA, Nowaczyk MJ, Wang W, Jaspers NG, Boerkoel CF. SMARCAL1 deficiency predisposes to non-Hodgkin lymphoma and hypersensitivity to genotoxic agents in vivo. <span><span class="ref-journal">Am J Med Genet A. </span>2012b;<span class="ref-vol">158A</span>:2204–13.</span> [<a href="/pmc/articles/PMC3429644/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3429644</span></a>] [<a href="/pubmed/22888040" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22888040</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.baradaranheravi.2008.2013">Baradaran-Heravi A, Thiel C, Rauch A, Zenker M, Boerkoel CF, Kaitila I. Clinical and genetic distinction of Schimke immuno-osseous dysplasia and cartilage-hair hypoplasia. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:2013–7.</span> [<a href="/pmc/articles/PMC2576743/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2576743</span></a>] [<a href="/pubmed/18627050" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18627050</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.boerkoel.2000.1">Boerkoel CF, O'Neill S, Andr&#x000e9; JL, Benke PJ, Bogdanov&#x000ed;&#x00107; R, Bulla M, Burguet A, Cockfield S, Cordeiro I, Ehrich JH, Fr&#x000fc;nd S, Geary DF, Ieshima A, Illies F, Joseph MW, Kaitila I, Lama G, Leheup B, Ludman MD, McLeod DR, Medeira A, Milford DV, Orm&#x000e4;l&#x000e4; T, Rener-Primec Z, Santava A, Santos HG, Schmidt B, Smith GC, Spranger J, Zupancic N, Weksberg R. Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. <span><span class="ref-journal">Eur J Pediatr. </span>2000;<span class="ref-vol">159</span>:1–7.</span> [<a href="/pubmed/10653321" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10653321</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.boerkoel.2002.215">Boerkoel CF, Takashima H, John J, Yan J, Stankiewicz P, Rosenbarker L, Andr&#x000e9; JL, Bogdanovic R, Burguet A, Cockfield S, Cordeiro I, Fr&#x000fc;nd S, Illies F, Joseph M, Kaitila I, Lama G, Loirat C, McLeod DR, Milford DV, Petty EM, Rodrigo F, Saraiva JM, Schmidt B, Smith GC, Spranger J, Stein A, Thiele H, Tizard J, Weksberg R, Lupski JR, Stockton DW. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. <span><span class="ref-journal">Nat Genet. </span>2002;<span class="ref-vol">30</span>:215–20.</span> [<a href="/pubmed/11799392" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11799392</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.b_kenkamp.2005.1724">B&#x000f6;kenkamp A, deJong M, van Wijk JA, Block D, van Hagen JM, Ludwig M. R561C missense mutation in the SMARCAL1 gene associated with mild Schimke immuno-osseous dysplasia. <span><span class="ref-journal">Pediatr Nephrol. </span>2005;<span class="ref-vol">20</span>:1724–8.</span> [<a href="/pubmed/16237566" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16237566</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.castriotascanderbeg.1997.854">Castriota-Scanderbeg A, Mingarelli R, Caramia G, Osimani P, Lachman RS, Rimoin DL, Wilcox WR, Dallapiccola B. Spondylo-mesomelic-acrodysplasia with joint dislocations and severe combined immunodeficiency: a newly recognised immuno-osseous dysplasia. <span><span class="ref-journal">J Med Genet. </span>1997;<span class="ref-vol">34</span>:854–6.</span> [<a href="/pmc/articles/PMC1051096/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1051096</span></a>] [<a href="/pubmed/9350822" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9350822</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.ciccia.2009.2415">Ciccia A, Bredemeyer AL, Sowa ME, Terret ME, Jallepalli PV, Harper JW, Elledge SJ. The SIOD disorder protein SMARCAL1 is an RPA-interacting protein involved in replication fork restart. <span><span class="ref-journal">Genes Dev. </span>2009;<span class="ref-vol">23</span>:2415–25.</span> [<a href="/pmc/articles/PMC2764500/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2764500</span></a>] [<a href="/pubmed/19793862" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19793862</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.clewing.2007a.122">Clewing JM, Antalfy BC, L&#x000fc;cke T, Najafian B, Marwedel KM, Hori A, Powel RM, Do AF, Najera L, SantaCruz K, Hicks MJ, Armstrong DL, Boerkoel CF. Schimke immuno-osseous dysplasia: a clinicopathological correlation. <span><span class="ref-journal">J Med Genet. </span>2007a;<span class="ref-vol">44</span>:122–30.</span> [<a href="/pmc/articles/PMC2598061/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2598061</span></a>] [<a href="/pubmed/16840568" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16840568</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.clewing.2007b.273">Clewing JM, Fryssira H, Goodman D, Smithson SF, Sloan EA, Lou S, Huang Y, Choi K, L&#x000fc;cke T, Alpay H, Andr&#x000e9; JL, Asakura Y, Biebuyck-Gouge N, Bogdanovic R, Bonneau D, Cancrini C, Cochat P, Cockfield S, Collard L, Cordeiro I, Cormier-Daire V, Cransberg K, Cutka K, Deschenes G, Ehrich JH, Fr&#x000fc;nd S, Georgaki H, Guillen-Navarro E, Hinkelmann B, Kanariou M, Kasap B, Kilic SS, Lama G, Lamfers P, Loirat C, Majore S, Milford D, Morin D, Ozdemir N, Pontz BF, Proesmans W, Psoni S, Reichenbach H, Reif S, Rusu C, Saraiva JM, Sakallioglu O, Schmidt B, Shoemaker L, Sigaudy S, Smith G, Sotsiou F, Stajic N, Stein A, Stray-Pedersen A, Taha D, Taque S, Tizard J, Tsimaratos M, Wong NA, Boerkoel CF. Schimke immunoosseous dysplasia: suggestions of genetic diversity. <span><span class="ref-journal">Hum Mutat. </span>2007b;<span class="ref-vol">28</span>:273–83.</span> [<a href="/pubmed/17089404" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17089404</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.coleman.2000.274">Coleman MA, Eisen JA, Mohrenweiser HW. Cloning and characterization of HARP/SMARCAL1: a prokaryotic HepA-related SNF2 helicase protein from human and mouse. <span><span class="ref-journal">Genomics. </span>2000;<span class="ref-vol">65</span>:274–82.</span> [<a href="/pubmed/10857751" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10857751</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.dekel.2008.398">Dekel B, Metsuyanim S, Goldstein N, Pode-Shakked N, Kovalski Y, Cohen Y, Davidovits M, Anikster Y. Schimke immuno-osseous dysplasia: expression of SMARCAL1 in blood and kidney provides novel insight into disease phenotype. <span><span class="ref-journal">Pediatr Res. </span>2008;<span class="ref-vol">63</span>:398–403.</span> [<a href="/pubmed/18356746" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18356746</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.ehrich.1990.117">Ehrich JH, Offner G, Schirg E, Hoyer PF, Helmchen U, Brodehl J. Association of spondylo-epiphyseal dysplasia with nephrotic syndrome. <span><span class="ref-journal">Pediatr Nephrol. </span>1990;<span class="ref-vol">4</span>:117–21.</span> [<a href="/pubmed/2397176" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2397176</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.elizondo.2006.340">Elizondo LI, Huang C, Northrop JL, Deguchi K, Clewing JM, Armstrong DL, Boerkoel CF. Schimke immuno-osseous dysplasia: a cell autonomous disorder? <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:340–8.</span> [<a href="/pubmed/16419127" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16419127</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.havas.2001.673">Havas K, Whitehouse I, Owen-Hughes T. ATP-dependent chromatin remodeling activities. <span><span class="ref-journal">Cell Mol Life Sci. </span>2001;<span class="ref-vol">58</span>:673–82.</span> [<a href="/pubmed/11437229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11437229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.kaitila.1998.427">Kaitila I, Savilahti E, Orm&#x000e4;l&#x000e4; T. Autoimmune enteropathy in Schimke immunoosseous dysplasia. <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">77</span>:427–30.</span> [<a href="/pubmed/9632175" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9632175</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.kilic.2005.206">Kilic SS, Donmez O, Sloan EA, Elizondo LI, Huang C, Andr&#x000e9; JL, Bogdanovic R, Cockfield S, Cordeiro I, Deschenes G, Fr&#x000fc;nd S, Kaitila I, Lama G, Lamfers P, L&#x000fc;cke T, Milford DV, Najera L, Rodrigo F, Saraiva JM, Schmidt B, Smith GC, Stajic N, Stein A, Taha D, Wand D, Armstrong D, Boerkoel CF. Association of migraine-like headaches with Schimke immuno-osseous dysplasia. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">135</span>:206–10.</span> [<a href="/pubmed/15884045" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15884045</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.lama.1995.19">Lama G, Marrone N, Majorana M, Cirillo F, Salsano ME, Rinaldi MM. Spondyloepiphyseal dysplasia tarda and nephrotic syndrome in three siblings. <span><span class="ref-journal">Pediatr Nephrol. </span>1995;<span class="ref-vol">9</span>:19–23.</span> [<a href="/pubmed/7742215" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7742215</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.lou.2002.922">Lou S, Lamfers P, McGuire N, Boerkoel CF. Longevity in Schimke immuno-osseous dysplasia. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:922–5.</span> [<a href="/pmc/articles/PMC1757210/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1757210</span></a>] [<a href="/pubmed/12471207" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12471207</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.l_cke.2005a.202">L&#x000fc;cke T, Billing H, Sloan EA, Boerkoel CF, Franke D, Zimmering M, Ehrich JH, Das AM. Schimke-immuno-osseous dysplasia: new mutation with weak genotype-phenotype correlation in siblings. <span><span class="ref-journal">Am J Med Genet A. </span>2005a;<span class="ref-vol">135</span>:202–5.</span> [<a href="/pubmed/15880370" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15880370</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.l_cke.2005b.237">L&#x000fc;cke T, Ehrich JH, Das AM. Mitochondrial function in schimke-immunoosseous dysplasia. <span><span class="ref-journal">Metab Brain Dis. </span>2005b;<span class="ref-vol">20</span>:237–42.</span> [<a href="/pubmed/16167201" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16167201</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.l_cke.2006a.e400">L&#x000fc;cke T, Franke D, Clewing JM, Boerkoel CF, Ehrich JH, Das AM, Zivicnjak M. Schimke versus non-Schimke chronic kidney disease: an anthropometric approach. <span><span class="ref-journal">Pediatrics. </span>2006a;<span class="ref-vol">118</span>:e400–7.</span> [<a href="/pubmed/16816006" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16816006</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.l_cke.2009.482">L&#x000fc;cke T, Kanzelmeyer N, Baradaran-Heravi A, Boerkoel CF, Burg M, Ehrich JH, Pape L. Improved outcome with immunosuppressive monotherapy after renal transplantation in Schimke-immuno-osseous dysplasia. <span><span class="ref-journal">Pediatr Transplant. </span>2009;<span class="ref-vol">13</span>:482–9.</span> [<a href="/pubmed/18785907" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18785907</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.l_cke.2004.672">L&#x000fc;cke T, Marwedel KM, Kanzelmeyer NK, Hori A, Offner G, Kreipe HH, Ehrich JH, Das AM. Generalized atherosclerosis sparing the transplanted kidney in Schimke disease. <span><span class="ref-journal">Pediatr Nephrol. </span>2004;<span class="ref-vol">19</span>:672–5.</span> [<a href="/pubmed/15054643" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15054643</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.l_cke.2006b.678">L&#x000fc;cke T, Tsikas D, Kanzelmeyer NK, Boerkoel CF, Clewing JM, Vaske B, Ehrich JH, Das AM. Vaso-occlusion in Schimke-immuno-osseous dysplasia: is the NO pathway involved? <span><span class="ref-journal">Horm Metab Res. </span>2006b;<span class="ref-vol">38</span>:678–82.</span> [<a href="/pubmed/17075778" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17075778</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.morimoto">Morimoto M, Cho KS, Myung C, Beirnes K, Leung D, Fam HK, Choi K, Huang Y, Lou S, Wang KJ, Najafian B, Bridgewater D, Boerkoel CF. Impaired Notch signaling in Schimke immuno-osseous dyplasia. Submitted.</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.morimoto.2012a.29s">Morimoto M, K&#x000e9;rour&#x000e9;dan O, Gendronneau M, Shuen C, Baradaran-Heravi A, Asakura Y, Basiratnia M, Bogdanovic R, Bonneau D, Buck A, Charrow J, Cochat P, Dehaai KA, Fenk&#x000e7;i MS, Frange P, Fr&#x000fc;nd S, Fryssira H, Keller K, Kirmani S, Kobelka C, Kohler K, Lewis DB, Massella L, McLeod DR, Milford DV, Nobili F, Olney AH, Semerci CN, Stajic N, Stein A, Taque S, Zonana J, L&#x000fc;cke T, Hendson G, Bonnaure-Mallet M, Boerkoel CF. Dental abnormalities in Schimke immuno-osseous dysplasia. <span><span class="ref-journal">J Dent Res. </span>2012a;<span class="ref-vol">91</span>:29S–37S.</span> [<a href="/pmc/articles/PMC3383106/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3383106</span></a>] [<a href="/pubmed/22699664" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22699664</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.morimoto.2015.609">Morimoto M, Wang KJ, Yu Z, Gormley AK, Parham D, Bogdanovic R, L&#x000fc;cke T, Mayfield C, Weksberg R, Hendson G, Boerkoel CF. Transcriptional and posttranscriptional mechanisms contribute to the dysregulation of elastogenesis in Schimke immuno-osseous dysplasia. <span><span class="ref-journal">Pediatr Res. </span>2015;<span class="ref-vol">78</span>:609–17.</span> [<a href="/pubmed/26309238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26309238</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.morimoto.2012b.70">Morimoto M, Yu Z, Stenzel P, Clewing JM, Najafian B, Mayfield C, Hendson G, Weinkauf JG, Gormley AK, Parham DM, Ponniah U, Andr&#x000e9; JL, Asakura Y, Basiratnia M, Bogdanovi&#x00107; R, Bokenkamp A, Bonneau D, Buck A, Charrow J, Cochat P, Cordeiro I, Deschenes G, Fenk&#x000e7;i MS, Frange P, Fr&#x000fc;nd S, Fryssira H, Guillen-Navarro E, Keller K, Kirmani S, Kobelka C, Lamfers P, Levtchenko E, Lewis DB, Massella L, McLeod DR, Milford DV, Nobili F, Saraiva JM, Semerci CN, Shoemaker L, Staji&#x00107; N, Stein A, Taha D, Wand D, Zonana J, L&#x000fc;cke T, Boerkoel CF. Reduced elastogenesis: a clue to the arteriosclerosis and emphysematous changes in Schimke immuno-osseous dysplasia? <span><span class="ref-journal">Orphanet J Rare Dis. </span>2012b;<span class="ref-vol">7</span>:70.</span> [<a href="/pmc/articles/PMC3568709/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3568709</span></a>] [<a href="/pubmed/22998683" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22998683</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.murea.2010.514">Murea M, Park JK, Sharma S, Kato H, Gruenwald A, Niranjan T, Si H, Thomas DB, Pullman JM, Melamed ML, Susztak K. Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. <span><span class="ref-journal">Kidney Int. </span>2010;<span class="ref-vol">78</span>:514–22.</span> [<a href="/pmc/articles/PMC3164583/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3164583</span></a>] [<a href="/pubmed/20531454" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20531454</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.muthuswami.2000.7648">Muthuswami R, Truman PA, Mesner LD, Hockensmith JW. A eukaryotic SWI2/SNF2 domain, an exquisite detector of double-stranded to single-stranded DNA transition elements. <span><span class="ref-journal">J Biol Chem. </span>2000;<span class="ref-vol">275</span>:7648–55.</span> [<a href="/pubmed/10713074" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10713074</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.niranjan.2008.290">Niranjan T, Bielesz B, Gruenwald A, Ponda MP, Kopp JB, Thomas DB, Susztak K. The Notch pathway in podocytes plays a role in the development of glomerular disease. <span><span class="ref-journal">Nat Med. </span>2008;<span class="ref-vol">14</span>:290–8.</span> [<a href="/pubmed/18311147" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18311147</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.pazin.1997.737">Pazin MJ, Kadonaga JT. SWI2/SNF2 and related proteins: ATP-driven motors that disrupt protein-DNA interactions? <span><span class="ref-journal">Cell. </span>1997;<span class="ref-vol">88</span>:737–40.</span> [<a href="/pubmed/9118215" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9118215</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.petty.2000.882">Petty EM, Yanik GA, Hutchinson RJ, Alter BP, Schmalstieg FC, Levine JE, Ginsburg D, Robillard JE, Castle VP. Successful bone marrow transplantation in a patient with Schimke immuno- osseous dysplasia. <span><span class="ref-journal">J Pediatr. </span>2000;<span class="ref-vol">137</span>:882–6.</span> [<a href="/pubmed/11113849" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11113849</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.postow.2009.35951">Postow L, Woo EM, Chait BT, Funabiki H. Identification of SMARCAL1 as a component of the DNA damage response. <span><span class="ref-journal">J Biol Chem. </span>2009;<span class="ref-vol">284</span>:35951–61.</span> [<a href="/pmc/articles/PMC2791023/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2791023</span></a>] [<a href="/pubmed/19841479" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19841479</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.puel.1998.394">Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. <span><span class="ref-journal">Nat Genet. </span>1998;<span class="ref-vol">20</span>:394–7.</span> [<a href="/pubmed/9843216" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9843216</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.ramanan.2000.173">Ramanan AV, Hussain K, Hird M, Gaspar HB. Short limbed skeletal dysplasia associated with combined immunodeficiency and congenital subglottic stenosis: a new constellation of features. <span><span class="ref-journal">Clin Dysmorphol. </span>2000;<span class="ref-vol">9</span>:173–6.</span> [<a href="/pubmed/10955476" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10955476</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.roifman.2000.2803">Roifman CM, Zhang J, Chitayat D, Sharfe N. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. <span><span class="ref-journal">Blood. </span>2000;<span class="ref-vol">96</span>:2803–7.</span> [<a href="/pubmed/11023514" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11023514</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.sanyal.2015.355">Sanyal M, Morimoto M, Baradaran-Heravi A, Choi K, Kambham N, Jensen K, Dutt S, Dionis-Petersen KY, Liu LX, Felix K, Mayfield C, Dekel B, Bokenkamp A, Fryssira H, Guillen-Navarro E, Lama G, Brugnara M, L&#x000fc;cke T, Olney AH, Hunley TE, Polat AI, Yis U, Bogdanovic R, Mitrovic K, Berry S, Najera L, Najafian B, Gentile M, Nur Semerci C, Tsimaratos M, Lewis DB, Boerkoel CF. Lack of IL7R&#x003b1; expression in T cells is a hallmark of T-cell immunodeficiency in Schimke immuno-osseous dysplasia (SIOD). <span><span class="ref-journal">Clin Immunol. </span>2015;<span class="ref-vol">161</span>:355–65.</span> [<a href="/pubmed/26499378" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26499378</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.spranger.1991.64">Spranger J, Hinkel GK, Stoss H, Thoenes W, Wargowski D, Zepp F. Schimke immuno-osseous dysplasia: a newly recognized multisystem disease. <span><span class="ref-journal">J Pediatr. </span>1991;<span class="ref-vol">119</span>:64–72.</span> [<a href="/pubmed/2066860" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2066860</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.thomas.2004.507">Thomas SE, Hutchinson RJ, Debroy M, Magee JC. Successful renal transplantation following prior bone marrow transplantation in pediatric patients. <span><span class="ref-journal">Pediatr Transplant. </span>2004;<span class="ref-vol">8</span>:507–12.</span> [<a href="/pubmed/15367289" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15367289</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.urb_n.2002.30">Urb&#x000e1;n Z, Riazi S, Seidl TL, Katahira J, Smoot LB, Chitayat D, Boyd CD, Hinek A. Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">71</span>:30–44.</span> [<a href="/pmc/articles/PMC384991/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC384991</span></a>] [<a href="/pubmed/12016585" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12016585</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.yuan.2009.2394">Yuan J, Ghosal G, Chen J. The annealing helicase HARP protects stalled replication forks. <span><span class="ref-journal">Genes Dev. </span>2009;<span class="ref-vol">23</span>:2394–9.</span> [<a href="/pmc/articles/PMC2764499/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2764499</span></a>] [<a href="/pubmed/19793864" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19793864</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.yusufzai.2008.748">Yusufzai T, Kadonaga JT. HARP is an ATP-driven annealing helicase. <span><span class="ref-journal">Science. </span>2008;<span class="ref-vol">322</span>:748–50.</span> [<a href="/pmc/articles/PMC2587503/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2587503</span></a>] [<a href="/pubmed/18974355" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18974355</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.yusufzai.2009.2400">Yusufzai T, Kong X, Yokomori K, Kadonaga JT. The annealing helicase HARP is recruited to DNA repair sites via an interaction with RPA. <span><span class="ref-journal">Genes Dev. </span>2009;<span class="ref-vol">23</span>:2400–4.</span> [<a href="/pmc/articles/PMC2764493/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2764493</span></a>] [<a href="/pubmed/19793863" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19793863</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="siod.REF.zieg.2011.27">Zieg J, Krepelova A, Baradaran-Heravi A, Levtchenko E, Guill&#x000e9;n-Navarro E, Balascakova M, Sukova M, Seeman T, Dusek J, Simankova N, Rosik T, Skalova S, Lebl J, Boerkoel CF. Rituximab resistant evans syndrome and autoimmunity in Schimke immuno-osseous dysplasia. <span><span class="ref-journal">Pediatr Rheumatol Online J. </span>2011;<span class="ref-vol">9</span>:27.</span> [<a href="/pmc/articles/PMC3184066/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3184066</span></a>] [<a href="/pubmed/21914180" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21914180</span></a>]</div></li></ul></div></div><div id="siod.Chapter_Notes"><h2 id="_siod_Chapter_Notes_">Chapter Notes</h2><div id="siod.Author_History"><h3>Author History</h3><p>Alireza Baradaran-Heravi, MD; University of British Columbia (2011-2016)<br />Cornelius F Boerkoel, MD, PhD (2002-present) <br />Leah I Elizondo, BSc; Baylor College of Medicine (2006-2011)<br />David B Lewis, MD (2016-present)<br />Shu Lou, MD; Baylor College of Medicine (2002-2006)<br />Thomas L&#x000fc;cke, MD, PhD (2006-present) <br />Marie Morimoto, BSc (2011-present)</p></div><div id="siod.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>11 February 2016 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 August 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 December 2011 (cd) Revision: prenatal testing available clinically</div></li><li class="half_rhythm"><div>22 March 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 December 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>30 August 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>1 October 2002 (me) Review posted live</div></li><li class="half_rhythm"><div>18 June 2002 (cfb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1376</span><span class="label">PMID: <a href="/pubmed/20301550" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301550</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/salih-myo/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/schmid-mcd/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1376&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1376/?report=reader">PubReader</a></li><li><a href="/books/NBK1376/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1376" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1376" style="display:none" title="Cite this Page"><div class="bk_tt">Morimoto M, Lewis DB, Lücke T, et al. Schimke Immunoosseous Dysplasia. 2002 Oct 1 [Updated 2016 Feb 11]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1376/pdf/Bookshelf_NBK1376.pdf">PDF version of this page</a> (471K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#siod.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#siod.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#siod.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#siod.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#siod.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#siod.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#siod.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#siod.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#siod.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#siod.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#siod.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=50485[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SMARCAL1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1480386" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1480386" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1480386" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1480386" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22420014" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Cartilage-Hair Hypoplasia – Anauxetic Dysplasia Spectrum Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Cartilage-Hair Hypoplasia – Anauxetic Dysplasia Spectrum Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mäkitie O, Vakkilainen S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301501" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Polycystic Kidney Disease, Autosomal Recessive</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Polycystic Kidney Disease, Autosomal Recessive<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sweeney WE, Avner ED. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301489" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bali DS, Chen YT, Austin S, Goldstein JL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301584" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Severe Combined Immunodeficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Severe Combined Immunodeficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Allenspach E, Rawlings DJ, Scharenberg AM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301575" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mehta PA, Tolar J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301550" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301550" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0417c2dde08911692c18aa">Schimke Immunoosseous Dysplasia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Schimke Immunoosseous Dysplasia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:15:30-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D69A8E040458100000000084402F2&amp;ncbi_session=CE8D69A8E0417C11_2116SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1376%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1376&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1376/&amp;ncbi_pagename=Schimke Immunoosseous Dysplasia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D69A8E0417C11_2116SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>